Measuring Health-Related Quality of Life in Thyroid Eye Disease

被引:7
作者
Sharma, Anu [1 ]
Stan, Marius N. [2 ]
Rootman, Dan B. [3 ,4 ]
机构
[1] Univ Utah, Div Endocrinol Metab & Diabet, Sch Med, Salt Lake City, UT 84112 USA
[2] Mayo Clin, Div Endocrinol, Rochester, MN 55905 USA
[3] Univ Calif Los Angeles, Stein Eye Inst, Los Angeles, CA 90095 USA
[4] Univ Calif Los Angeles, Doheny Eye Inst, Los Angeles, CA 90095 USA
关键词
thyroid eye disease; quality of life; measurement; patient reported outcomes; VISUAL FUNCTION QUESTIONNAIRE; GRAVES ORBITOPATHY; GO-QOL; TED-QOL; ANTITHYROID DRUGS; FOLLOW-UP; OPHTHALMOPATHY; RELIABILITY; VALIDITY; MODERATE;
D O I
10.1210/clinem/dgac230
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Health-related quality of life (HQOL) is a concept that aims to understand the totality of an individual's experience of their disease state. This can include the physical, psychosocial, emotional, and psychological effects of a disease state. A complex and multifactorial concept, HQOL can be challenging to measure accurately and reliably. Thyroid eye disease (TED), as a multifaceted physically debilitating and facial disfiguring disorder, presents unique challenges and opportunities in the measurement of HQOL. Multiple distinct tools have been developed for this purpose, each has been constructed, assessed, and utilized. This discussion surveys the landscape of TED-related QOL measurement and presents challenges for the future. Clinicians and clinical researchers should implement TED-related QOL measurement as part of routine TED care and as a primary outcome in TED clinical trials. We recommend utilizing the Graves' ophthalmopathy (GO)-QOL routinely in clinical practice and as a primary outcome in TED clinical trials. If the GO-QOL is too time-consuming or in mild TED, a faster alternative is the TED-QOL.
引用
收藏
页码:S27 / S35
页数:9
相关论文
共 60 条
[1]   Graves' disease:: A long-term quality-of-life follow up of patients Randomized to treatment with antithyroid drugs, radioiodine, or surgery [J].
Abraham-Nordling, M ;
Törring, O ;
Hamberger, B ;
Lundell, G ;
Tallstedt, L ;
Calissendorff, J ;
Wallin, G .
THYROID, 2005, 15 (11) :1279-1286
[2]   Thyroid-associated ophthalmopathy; quality of life follow-up of patients randomized to treatment with antithyroid drugs or radioiodine [J].
Abraham-Nordling, Mirna ;
Wallin, Goran ;
Traisk, Frank ;
Berg, Gertrud ;
Calissendorff, Jan ;
Hallengren, Bengt ;
Hedner, Pavo ;
Lantz, Mikael ;
Nystrom, Ernst ;
Asman, Peter ;
Lundell, Goran ;
Torring, Ove .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2010, 163 (04) :651-657
[3]   Development and validation of a quality of life instrument for cutaneous diseases [J].
Anderson, RT ;
Rajagopalan, R .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1997, 37 (01) :41-50
[4]  
Bahmani-Kashkouli Mohsen, 2009, J Ophthalmic Vis Res, V4, P164
[5]   The 2021 European Group on Graves' orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves' orbitopathy [J].
Bartalena, L. ;
Kahaly, G. J. ;
Baldeschi, L. ;
Dayan, C. M. ;
Eckstein, A. ;
Marcocci, C. ;
Marino, M. ;
Vaidya, B. ;
Wiersinga, W. M. .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2021, 185 (04) :G43-G67
[6]   Efficacy and Safety of Three Different Cumulative Doses of Intravenous Methylprednisolone for Moderate to Severe and Active Graves' Orbitopathy [J].
Bartalena, L. ;
Krassas, G. E. ;
Wiersinga, W. ;
Marcocci, C. ;
Salvi, M. ;
Daumerie, C. ;
Bournaud, C. ;
Stahl, M. ;
Sassi, L. ;
Veronesi, G. ;
Azzolini, C. ;
Boboridis, K. G. ;
Mourits, M. P. ;
Soeters, M. R. ;
Baldeschi, L. ;
Nardi, M. ;
Curro, N. ;
Boschi, A. ;
Bernard, M. ;
von Arx, G. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (12) :4454-4463
[7]   Proposal for Standardization of Primary and Secondary Outcomes in Patients with Active, Moderate-to-Severe Graves' Orbitopathy [J].
Bartalena, Luigi ;
Wiersinga, Wilmar M. .
EUROPEAN THYROID JOURNAL, 2020, 9 (SUPPL 1) :3-16
[8]   THE SICKNESS IMPACT PROFILE - DEVELOPMENT AND FINAL REVISION OF A HEALTH-STATUS MEASURE [J].
BERGNER, M ;
BOBBITT, RA ;
CARTER, WB ;
GILSON, BS .
MEDICAL CARE, 1981, 19 (08) :787-805
[9]   Evaluation of the national eye institute visual function questionnaire in Graves' ophthalmopathy [J].
Bradley, Elizabeth A. ;
Sloan, Jeff A. ;
Novotny, Paul J. ;
Garrity, James A. ;
Woog, John J. ;
West, Sheila K. .
OPHTHALMOLOGY, 2006, 113 (08) :1450-1454
[10]   Assessing Graves' ophthalmopathy-specific quality of life in Korean patients [J].
Choi, Y. J. ;
Lim, H. T. ;
Lee, S. J. ;
Lee, S. Y. ;
Yoon, J. S. .
EYE, 2012, 26 (04) :544-551